Premium Information is available for this item - Upgrade for $1 a day
6505-01-064-2672
Usp Oxymetazoline Hydrochloride Nasal Solution
6505010642672 010642672 NDC00085-0756-03
INC: 30975 Oxymetazoline Hydrochloride Nasal Solution
November 2023
7
Marketplace 6505-01-064-2672
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-064-2672 5+ Documents (More...)
,NDC00085-0756-03 RQST NE Updated Every Day 6505-01-064-2672 RQST Updated Every Day 6505-01-064-2672
RQST NE Related Documents ,NDC00085-0756-03 ,NDC00085-0756-03 ,NDC00085-0756-03 ,NDC00085-0756-03 RQST
08736505012410873 012410873 6505-27-004-7237 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-064-2672
43-000-7175 Oxymetazoline Hydrochloride Nasal Solution www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-064-2672
6505010642672 010642672,NDC00085-0756-03 0756-03 6505001178564001178564,AFRINNASALSPRAYAFRINNASALSPRAY
6505 -01-064-2672 08736505012410873 012410873 AFRINNASALSPRAY 6505-43-000-7175 6505/us 6505-01-064-2672
6505010642672 010642672,NDC00085-0756-03 001178564,AFRINNASALSPRAY 6505001178564001178564,AFRINNASALSPRAYAFRINNASALSPRAY
6505-01-064-2672 https //www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-117-85646505001178564001178564
6505010642672 010642672,NDC00085-0756-03 tr 6505-27-004-7237 Oxymetazoline Hydrochloride https/
6505-43-000-7175 012410873 6505-27-004-7237 -7175 6505-01 001178564 ,AFRINNASALSPRAY 6505/us 6505-01-064-2672
Restrictions 6505-01-064-2672
6505-01-064-2672 is a Usp Oxymetazoline Hydrochloride Nasal Solution that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-01-064-2672
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-064-2672
- Part Number
- Manufacturer
- Status
- NDC00085-0756-03
- Manufacturer
- 55363 - Dept Of Health Education And Welfare (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-01-064-2672
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 0.050 Percentage, W/V Oxymetazoline Hydrochloride Active Ingredient
- Pharmaceutical Vehicle Type [AKJQ]
- Aqueous
- Administration [CSGS]
- Nasal
- Primary Container Type [CQCT]
- Bottle, Squeeze Spray
- Primary Container Content Quantity [CRLK]
- 3.000 Milliliters
- Total Primary Container Quantity [CSCW]
- 1
Similar Supply Items to 6505-01-064-2672
Freight Information 6505-01-064-2672
6505-01-064-2672 has freight characteristics.. 6505-01-064-2672 has a variance between NMFC and UFC when transported by rail and the description should be consulted.